One hundred and fourteen cases ofsuspected malabsorption had one or more butterfat tests. These were divided into absorbers and malabsorbers without knowledge of the butterfat test results.
Introduction
The diagnosis of malabsorption is currently based on a collection of non-specific symptoms, signs and blood tests which guide the physician to the appropriate specific investigations of duodenal or jejunal biopsy, small bowel enema, endoscopic retrograde cholangiopancreatography (ERCP) or pancreatic studies.' The latter are unpleasant, expensive in terms of medical time and resources, and are potentially hazardous. Thus there is a need for a reliable, cheap and quick screening test.
Fat malabsorption is present in over 75% of patients with coeliac disease and the majority of patients with pancreatic or overgrowth malabsorption. Tests for fat malabsorption remain the most commonly used screening tool. Faecal fat estimation requires a strict diet, collection ofall stool over 3 days and, ideally, the use of markers to In an earlier evaluation in our own department, the butterfat test was compared with faecal fat collections in 25 subjects with suspected malabsorption in whom a final diagnosis had been established. The two tests showed a fair and significant correlation (r = 0.61, P < 0.01). From these results it was decided that a change in LSI at 2 hours of over 40 units should be considered normal, less than 20 units abnormal and the range between 20 and 40 units borderline. This broadly agrees with a cut-off level of 20 units previously suggested. 4 Data for the present study were gathered from a retrospective review of the case notes for all patients undergoing the butterfat test from 1980 to 1989. Patients were felt to be malabsorbing if they had a positive duodenal or jejunal biopsy, an abnormal ERCP or pancreatic function test, or an elevated faecal fat. Other clinical data considered were weight loss, response to treatment, steatorrhoea, folate and albumin levels and X-ray studies. Patients were excluded if the data were inadequate or conflicting, in the presence of severe underlying disease (including depression) unless fully investigated, and if suffering from giardiasis. The data were collected retrospectively by one of the authors (GDH). The absorption status for each case was assessed without knowledge of the patient's name or butterfat result. The specificity, sensitivity and predictive values were calculated for increments of five from 10 to 40 LSI units as a simple cut-offvalue and the value of a 'borderline' zone assessed.
Results
A total of 81 patients received a total of97 butterfat tests. The characteristics of this population are shown in Table I . The main analysis is set out in Table II and the separation of the two groups is illustrated in Figure 1 . As can be seen from the analysis, a simple cut-off value of 20 LSI units at or below which malabsorption is likely appears to give the best balance of sensitivity, specificity and predictive values. Even if repeat tests are included there is only a slight loss of accuracy overall.
If20-30 units is taken as an equivocal range, five cases (6%) fall into this band. The net result as shown in Table II improves the tests' performance still further. Widening this band to an upper limit of 40 units has a negative effect and unnecessarily doubles the number of grey cases.
Of the patients with false negative results one had pancreatic and three coeliac malabsorption. The patient with pancreatic disease may have taken pancreatic enzyme replacement ('pancrex') and one of the coeliac patients may have already started a the radioisotope technique, but the determination of serum lipid changes is best achieved by titrating the dose of body weight and using sufficient carbohydrate as a carrier.4 Secondly they used the peak level of optical density as their discriminating measure and not the level at 2 hours. As Gardiner's work demonstrates, in patients with malabsorption, not only is the peak optical density reduced, but the rate of rise is much lower. We would suggest that a sample at 2 hours is more sensitive for both effects.
The butterfat test performs well when assessed to the criteria set down by Reigelman.8 It is simple to perform and measurement of the light scattering intensity is a quick, cheap and simple procedure performed on a nephelometer (cost approximately £1,500) or a fluorimeter (possessed by almost all hospital laboratories). The results are reproducible within and between both patients and observers, and closely reflect the observed rise in lipids. 7 
